Xilio Therapeutics (XLO) Short Interest Ratio & Short Volume $0.68 -0.01 (-0.93%) As of 06/12/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Xilio Therapeutics Short Interest DataXilio Therapeutics (XLO) has a short interest of 791,500 shares, representing 4.82% of the float (the number of shares available for trading by the public). This marks a -35.12% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 1.40 million shares to cover all short positions.Current Short Interest791,500 sharesPrevious Short Interest1,220,000 sharesChange Vs. Previous Month-35.12%Dollar Volume Sold Short$893.60 thousandShort Interest Ratio0.6 Days to CoverLast Record DateMay 31, 2025Outstanding Shares51,782,000 sharesFloat Size16,420,000 sharesShort Percent of Float4.82%Today's Trading Volume448,639 sharesAverage Trading Volume1,402,660 sharesToday's Volume Vs. Average32% Short Selling Xilio Therapeutics? Sign up to receive the latest short interest report for Xilio Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartXLO Short Interest Over TimeXLO Days to Cover Over TimeXLO Percentage of Float Shorted Over Time Xilio Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/2025791,500 shares $893.60 thousand -35.1%4.8%0.6 $1.13 5/15/20251,220,000 shares $976 thousand +247.4%7.4%1.1 $0.80 4/30/2025351,200 shares $268.91 thousand -37.5%2.2%0.1 $0.77 4/15/2025562,300 shares $400.36 thousand -12.8%3.6%0.2 $0.71 3/31/2025644,500 shares $466.88 thousand +12.0%3.9%0.2 $0.72 3/15/2025575,500 shares $460.52 thousand -17.2%3.5%0.1 $0.80 2/28/2025694,600 shares $629.31 thousand -61.6%4.7%0.2 $0.91 2/15/20251,810,000 shares $2.06 million +809.1%10.7%0.5 $1.14 1/31/2025199,100 shares $140.37 thousand -6.6%1.0%0.4 $0.71 1/15/2025213,100 shares $230.15 thousand -44.5%1.1%0.4 $1.08 Get the Latest News and Ratings for XLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/2024384,100 shares $366.82 thousand +221.7%2.1%0.8 $0.96 12/15/2024119,400 shares $115.67 thousand -31.9%0.6%0.3 $0.97 11/30/2024175,300 shares $191.08 thousand +317.4%0.9%0.7 $1.09 11/15/202442,000 shares $43.68 thousand -89.4%0.2%0.2 $1.04 10/31/2024396,100 shares $503.05 thousand +278.0%1.9%1.6 $1.27 10/15/2024104,800 shares $83.84 thousand -25.2%0.5%0.7 $0.80 9/30/2024140,100 shares $110.36 thousand +846.6%0.7%1 $0.79 9/15/202414,800 shares $12.14 thousand -52.3%0.1%0.1 $0.82 8/31/202431,000 shares $26.59 thousand -72.2%0.1%0.2 $0.86 8/15/2024111,300 shares $92.38 thousand -6.2%0.5%0.5 $0.83 7/31/2024118,600 shares $112.65 thousand -18.2%0.6%0.5 $0.95 7/15/2024144,900 shares $146.35 thousand +23.1%0.7%0.5 $1.01 6/30/2024117,700 shares $111.52 thousand +56.9%0.6%0.3 $0.95 6/15/202475,000 shares $76.50 thousand -83.2%0.4%0.1 $1.02 5/31/2024445,000 shares $480.60 thousand +6.2%2.2%0.3 $1.08 5/15/2024419,100 shares $469.39 thousand -8.2%2.0%0.3 $1.12 4/30/2024456,500 shares $474.76 thousand +20.3%5.2%0.4 $1.04 4/15/2024379,500 shares $478.17 thousand +600.2%4.4%0.3 $1.26 3/31/202454,200 shares $58.54 thousand -5.9%0.7%0 $1.08 3/15/202457,600 shares $39.46 thousand +171.7%0.4%0.3 $0.69 2/29/202421,200 shares $15.03 thousand -37.3%0.2%0.1 $0.71 2/15/202433,800 shares $19.85 thousand +2,012.5%0.2%0.2 $0.59 1/31/20241,600 shares $1.04 thousand -75.4%0.0%0 $0.65 1/15/20246,500 shares $4.83 thousand +364.3%0.1%0 $0.74 12/31/20231,400 shares $770.00 -92.5%0.0%0 $0.55 12/15/202318,600 shares $13.21 thousand -65.6%0.1%0.4 $0.71 11/30/202354,100 shares $51.40 thousand +86.6%0.4%2.2 $0.95 11/15/202329,000 shares $38.86 thousand +14.6%0.2%1.5 $1.34 10/31/202325,300 shares $54.40 thousand -4.5%0.2%1.7 $2.15 10/15/202326,500 shares $46.38 thousand +7.7%0.2%2.2 $1.75Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 9/30/202324,600 shares $51.91 thousand +98.4%0.2%2.1 $2.11 9/15/202312,400 shares $29.26 thousand -77.0%0.1%1.1 $2.36 8/31/202353,900 shares $154.69 thousand -2.7%0.4%4 $2.87 8/15/202355,400 shares $151.24 thousand -7.1%0.4%4.2 $2.73 7/31/202359,600 shares $170.46 thousand -23.6%0.4%4.1 $2.86 7/15/202378,000 shares $206.70 thousand -4.5%0.6%4.9 $2.65 6/30/202381,700 shares $214.05 thousand -46.2%0.6%3.6 $2.62 6/15/2023151,800 shares $414.41 thousand -21.4%1.2%6.5 $2.73 5/31/2023193,100 shares $588.96 thousand -3.3%1.5%8.9 $3.05 5/15/2023199,600 shares $612.77 thousand +1.0%1.7%7.6 $3.07 4/30/2023197,600 shares $652.08 thousand -12.1%1.8%7 $3.30 4/15/2023224,700 shares $741.51 thousand +25.7%2.0%4.3 $3.30 3/31/2023178,700 shares $566.48 thousand +58.6%1.6%3.4 $3.17 3/15/2023112,700 shares $311.05 thousand +160.9%1.0%2.2 $2.76 2/28/202343,200 shares $155.95 thousand +77.1%0.4%0.9 $3.61 2/15/202324,400 shares $77.59 thousand -62.6%0.3%0.5 $3.18 1/31/202365,200 shares $237.98 thousand +239.6%0.7%1.3 $3.65 1/15/202319,200 shares $51.07 thousand -31.4%0.2%0.5 $2.66 12/30/202228,000 shares $75.32 thousand +1.8%0.3%1 $2.69 12/15/202227,500 shares $62.70 thousand -0.7%0.3%0.9 $2.28 11/30/202227,700 shares $67.03 thousand +12.2%0.3%0.3 $2.42 11/15/202224,700 shares $59.28 thousand +34.2%0.3%0.3 $2.40 10/31/202218,400 shares $43.06 thousand -41.4%0.2%0.2 $2.34 10/15/202231,400 shares $72.22 thousand -34.0%0.3%0.3 $2.30 9/30/202247,600 shares $138.52 thousand -15.3%0.5%0.4 $2.91 9/15/202256,200 shares $177.03 thousand +72.4%0.6%0.4 $3.15 8/31/202232,600 shares $73.02 thousand -45.4%0.3%0.3 $2.24 8/15/202259,700 shares $146.27 thousand +114.8%0.6%0.5 $2.45 7/31/202227,800 shares $80.62 thousand -48.1%0.3%0.2 $2.90 7/15/202253,600 shares $165.62 thousand -31.9%0.5%0.5 $3.09 6/30/202278,700 shares $229.80 thousand -65.4%0.8%0.7 $2.92 6/15/2022227,400 shares $518.47 thousand -31.0%2.3%2.8 $2.28 5/31/2022329,400 shares $988.20 thousand -3.1%3.3%5.8 $3.00 5/15/2022339,800 shares $1.15 million +4.2%3.4%8.7 $3.37 4/30/2022326,200 shares $1.15 million +47.0%3.3%9.5 $3.53 4/15/2022221,900 shares $1.34 million -8.0%2.3%6.7 $6.04 3/31/2022241,200 shares $1.71 million +1.9%2.6%8.8 $7.07 3/15/2022236,700 shares $1.66 million +3.4%2.5%6.4 $7.01 2/28/2022228,900 shares $2.70 million -3.6%2.5%2.7 $11.78 2/15/2022237,400 shares $3.45 million -4.8%2.6%2.5 $14.54 1/31/2022249,400 shares $3.39 million -14.9%2.6%2.3 $13.61 1/15/2022292,900 shares $4.25 million -26.9%3.0%2.3 $14.52 12/31/2021400,900 shares $6.41 million No ChangeN/A2.3 $16.00 XLO Short Interest - Frequently Asked Questions What is Xilio Therapeutics' current short interest? Short interest is the volume of Xilio Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 791,500 shares of XLO short. 4.82% of Xilio Therapeutics' shares are currently sold short. Learn More on Xilio Therapeutics' current short interest. What is a good short interest ratio for Xilio Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XLO shares currently have a short interest ratio of 1.0. Learn More on Xilio Therapeutics's short interest ratio. What is a good short interest percentage for Xilio Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.82% of Xilio Therapeutics' floating shares are currently sold short. Is Xilio Therapeutics' short interest increasing or decreasing? Xilio Therapeutics saw a decrease in short interest in the month of May. As of May 31st, there was short interest totaling 791,500 shares, a decrease of 35.1% from the previous total of 1,220,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Xilio Therapeutics' float size? Xilio Therapeutics currently has issued a total of 51,782,000 shares. Some of Xilio Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Xilio Therapeutics currently has a public float of 16,420,000 shares. How does Xilio Therapeutics' short interest compare to its competitors? 4.82% of Xilio Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Xilio Therapeutics: Eupraxia Pharmaceuticals Inc. (0.62%), Larimar Therapeutics, Inc. (10.35%), FitLife Brands, Inc. (0.24%), Alector, Inc. (8.88%), Black Diamond Therapeutics, Inc. (14.68%), Enanta Pharmaceuticals, Inc. (13.70%), Compugen Ltd. (1.82%), Greenwich LifeSciences, Inc. (16.03%), Protara Therapeutics, Inc. (12.08%), Protalix BioTherapeutics, Inc. (1.39%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Xilio Therapeutics stock? Short selling XLO is an investing strategy that aims to generate trading profit from Xilio Therapeutics as its price is falling. XLO shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Xilio Therapeutics? A short squeeze for Xilio Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XLO, which in turn drives the price of the stock up even further. How often is Xilio Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XLO, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies Eupraxia Pharmaceuticals Short Squeeze Larimar Therapeutics Short Squeeze FitLife Brands Short Squeeze Alector Short Squeeze Black Diamond Therapeutics Short Squeeze Enanta Pharmaceuticals Short Squeeze Compugen Short Squeeze Greenwich LifeSciences Short Squeeze Protara Therapeutics Short Squeeze Protalix BioTherapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XLO) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xilio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xilio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
